Recombinant Danio rerio Transmembrane Protein 14C, commonly referred to as tmem14c, is a protein derived from the zebrafish (Danio rerio). This protein is part of the transmembrane protein family and has been studied for its role in various biological processes. The recombinant form of this protein is produced through genetic engineering techniques, allowing researchers to study its functions and applications in a controlled manner.
TMEM14C is known to play a crucial role in mitochondrial heme metabolism, particularly in the context of erythropoiesis, which is the process of red blood cell production. In humans and other vertebrates, TMEM14C is essential for the import of protoporphyrinogen IX into the mitochondrial matrix, a critical step in heme synthesis and subsequent hemoglobin production . While the specific function of the zebrafish version may share similarities, detailed studies on its role in zebrafish are less extensive.
The recombinant Danio rerio Transmembrane Protein 14C is produced using recombinant DNA technology. This involves inserting the gene encoding tmem14c into an expression vector, which is then introduced into a host organism (such as bacteria or yeast) for protein production. The recombinant protein is typically purified and characterized for its structure and function.
| Characteristics | Description |
|---|---|
| Species | Danio rerio (Zebrafish) |
| Protein Name | Transmembrane Protein 14C |
| Tag Information | Determined during production |
| Storage Buffer | Tris-based buffer, 50% glycerol |
| Storage Conditions | Store at -20°C or -80°C; avoid repeated freezing and thawing |
Zebrafish are widely used in biomedical research due to their genetic similarity to humans, rapid breeding cycle, and ease of genetic manipulation. This makes them an ideal model for studying gene function and disease mechanisms, including those related to heme metabolism .
Essential for normal heme biosynthesis.
TMEM14C is an inner mitochondrial membrane protein that plays an essential role in erythroid mitochondrial heme metabolism. Research demonstrates that TMEM14C facilitates the import of protoporphyrinogen IX into the mitochondrial matrix for heme synthesis . This function is critical for erythropoiesis and proper red blood cell development. The protein is enriched in vertebrate hematopoietic tissues, suggesting its specialized role in blood cell formation .
In TMEM14C-deficient models, protoporphyrin IX synthesis is blocked, resulting in accumulation of porphyrin precursors . This disruption in heme synthesis leads to profound developmental consequences, including erythroid maturation arrest and embryonic lethality due to severe anemia in mouse models .
Danio rerio TMEM14C is a transmembrane protein with the following amino acid sequence:
MAVDWAGYGYAALVASGGVIGYVKAGSVPSLAAGLVFGGLAGFGAYQTSQDPGNIWVSLAASGTALAIMGKRFYNSRKITPAGLIAGASVLMLAKLGAGMLQKPQKS .
The protein has a full-length expression region spanning amino acids 1-107 . As an inner mitochondrial membrane protein, TMEM14C contains hydrophobic domains that anchor it within the membrane, allowing it to function in the transport of porphyrin compounds. The protein is identified in UniProt under accession number Q0P436 and has synonyms including c6orf53 and zgc:153439 .
Zebrafish (Danio rerio) has emerged as a valuable model for studying TMEM14C function for several reasons:
Zebrafish has been extensively used as a model organism for identifying genes required for early vertebrate development .
The transparency of zebrafish embryos allows for direct visualization of developmental processes, including those related to hematopoiesis.
Zebrafish develop tumors in a variety of tissues and are susceptible to chemical carcinogens and oncogenes in a manner similar to conventional mouse models .
Many spontaneous and chemically-induced tumor types in zebrafish are histologically similar to their mammalian counterparts .
The conservation of heme biosynthetic pathways between zebrafish and mammals makes it an excellent model for studying TMEM14C's role in erythropoiesis.
These characteristics make zebrafish an efficient and informative model system for investigating TMEM14C's biological functions and potential implications in disease states.
Several complementary techniques have proven effective for investigating TMEM14C function in erythroid cells:
Genetic Manipulation Approaches:
Functional Assessment Methods:
Biochemical Analysis:
Measurement of mitochondrial iron levels using inductively coupled plasma mass spectrometry
Assessment of enzyme activities including mitochondrial aconitase, ferrochelatase (FECH), and cytosolic xanthine oxidase to evaluate iron-sulfur cluster assembly
Quantification of porphyrin intermediates to identify metabolic blocks in the heme synthesis pathway
These methodological approaches provide complementary data that together build a comprehensive understanding of TMEM14C's role in erythroid development and heme metabolism.
Proper storage and handling of recombinant Danio rerio TMEM14C protein is critical for maintaining its structural integrity and biological activity:
Storage Conditions:
Handling Recommendations:
Quality Control Considerations:
Verify protein integrity by SDS-PAGE before experimental use
Confirm biological activity using appropriate functional assays
Consider including positive controls when evaluating TMEM14C function in experimental systems
Following these storage and handling protocols will help ensure consistent and reliable experimental results when working with recombinant Danio rerio TMEM14C.
Researchers have successfully employed several strategies to generate TMEM14C-deficient models:
CRISPR/Cas9 Genome Editing:
shRNA Silencing:
Knockout Cell Lines:
When implementing these approaches, researchers should include appropriate controls and validate TMEM14C depletion at both mRNA and protein levels to ensure experimental rigor and reproducibility.
TMEM14C deficiency has profound effects on erythroid development and heme metabolism, as demonstrated in multiple experimental systems:
Developmental Consequences:
In mouse models, TMEM14C deficiency results in embryonic lethality due to profound anemia
Flow cytometry analyses reveal a decrease in terminally differentiating TER119+ erythroid cells in Tmem14c-deficient fetal livers, while erythroid progenitor numbers remain unchanged
The defect is erythroid-specific, as other hematopoietic lineages develop normally in the absence of TMEM14C
Metabolic Disruptions:
Protoporphyrin IX synthesis is blocked in TMEM14C-deficient erythroid cells, leading to accumulation of porphyrin precursors
Both basal and differentiation-induced heme synthesis are reduced in TMEM14C-deficient cells, as measured by 55Fe labeling
The heme synthesis defect is not secondary to an erythroid differentiation defect but reflects direct involvement of TMEM14C in heme homeostasis
Cellular Functions:
TMEM14C does not regulate mitochondrial iron import, as mitochondrial iron levels remain normal in TMEM14C-deficient cells
Normal activity of mitochondrial aconitase, FECH, and cytosolic xanthine oxidase in TMEM14C-deficient cells indicates normal iron-sulfur cluster assembly
TMEM14C specifically facilitates the import of protoporphyrinogen IX into the mitochondrial matrix for heme synthesis
These findings establish TMEM14C as a critical component of the heme biosynthetic pathway, specifically involved in the transport of porphyrin intermediates across the mitochondrial membrane.
TMEM14C plays a specific role in mitochondrial porphyrin metabolism that distinguishes it from other aspects of mitochondrial function:
Specific Role in Porphyrin Transport:
TMEM14C facilitates the import of protoporphyrinogen IX into the mitochondrial matrix where it can be converted to protoporphyrin IX by PPOX and subsequently to heme by FECH
In TMEM14C-deficient cells, PPOX and FECH protein levels remain normal, indicating that TMEM14C does not regulate the expression of these enzymes
The block in protoporphyrin IX synthesis and accumulation of porphyrin precursors in TMEM14C-deficient cells points to a transport function rather than an enzymatic role
Independence from Iron Metabolism:
Mitochondrial iron levels, as measured by inductively coupled plasma mass spectrometry and 59Fe labeling, are similar in control and TMEM14C-deficient cells
Normal activity of iron-dependent enzymes in TMEM14C-deficient cells further confirms that TMEM14C does not directly affect iron metabolism
Cellular 55Fe uptake is decreased only in differentiating TMEM14C-deficient cells, likely reflecting the decreased demand for iron due to blocked heme synthesis rather than a direct effect on iron transport
These findings position TMEM14C as a specialized component of the heme biosynthetic pathway, with a specific role in facilitating the movement of porphyrin intermediates across the mitochondrial membrane for the final steps of heme synthesis.
Research has revealed important distinctions between heterozygous and homozygous TMEM14C deficiencies:
Homozygous Deficiency:
Heterozygous State:
This pattern suggests that TMEM14C functions in a dose-dependent manner, with one functional allele producing sufficient protein to maintain normal heme synthesis and erythroid development. This differs from some other genes involved in erythropoiesis that display haploinsufficiency, such as certain ribosomal protein genes in zebrafish that predispose to cancer when heterozygous .
Researchers working with recombinant TMEM14C may encounter several technical challenges:
Protein Stability Issues:
Expression and Purification Challenges:
Functional Assessment Difficulties:
Evaluating transport function in vitro requires appropriate membrane reconstitution systems
Distinguishing direct effects on porphyrin transport from secondary effects on erythroid differentiation requires careful experimental design
Measuring porphyrin intermediates can be challenging due to their chemical properties
To address these challenges, researchers should carefully optimize storage conditions, consider using specialized expression systems for membrane proteins, and employ multiple complementary approaches to assess TMEM14C function.
Distinguishing primary metabolic effects from secondary developmental consequences requires strategic experimental approaches:
Temporal Analysis:
Time-course experiments examining the sequence of biochemical and developmental changes can help establish causality
Quantification of heme synthesis rates and porphyrin intermediates at early time points before differentiation defects appear
Comparative Cell Systems:
Rescue Experiments:
Complementation with wild-type TMEM14C to determine if metabolic and developmental phenotypes are both rescued
Evaluation of whether bypassing the metabolic block can restore normal differentiation
Molecular Analysis:
These approaches collectively enable researchers to establish the primary function of TMEM14C in heme metabolism and differentiate it from secondary effects on erythroid development.
Several promising research directions could expand our understanding of TMEM14C in disease contexts:
Hematological Disorders:
Investigation of TMEM14C mutations or expression changes in congenital sideroblastic anemias
Exploration of TMEM14C's role in porphyrias and other disorders of heme metabolism
Assessment of whether TMEM14C dysfunction contributes to acquired anemias
Cancer Biology:
Examination of TMEM14C in cancer contexts, given that zebrafish develop malignant peripheral nerve sheath tumors and other tumor types
Investigation of how altered heme metabolism might contribute to cancer progression
Exploration of TMEM14C as a potential therapeutic target in cancers dependent on elevated heme synthesis
Mitochondrial Disorders:
Analysis of TMEM14C in broader mitochondrial dysfunction syndromes
Investigation of potential interactions between TMEM14C and other mitochondrial transporters
Exploration of whether TMEM14C function is altered in conditions of mitochondrial stress
These research avenues could yield important insights into the role of TMEM14C in human disease and potentially identify new therapeutic approaches for disorders involving disrupted heme metabolism.
Understanding TMEM14C function could inform therapeutic development in several ways:
Novel Drug Target Identification:
TMEM14C represents a potential therapeutic target for modulating heme synthesis in disorders of erythropoiesis
Small molecules that enhance TMEM14C function might benefit conditions with impaired heme synthesis
Conversely, inhibitors of TMEM14C could potentially address conditions with pathological overproduction of heme
Biomarker Development:
Patterns of porphyrin intermediate accumulation resulting from TMEM14C dysfunction could serve as biomarkers for certain hematological disorders
Changes in TMEM14C expression or function might indicate altered erythropoiesis in disease states
Gene Therapy Approaches:
Drug Screening Applications:
These potential therapeutic applications highlight the importance of continued research into TMEM14C's structure, function, and role in health and disease.